Physician profile
Roberto M Vendrell
NPI 1407830250
$15,081.80
in general payments reported to CMS, 2019-2025
16 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,627 · 2020: $163 · 2021: $122 · 2022: $219 · 2023: $897 · 2024: $3,690 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,675 · Consulting Fee: $2,275.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,674.90 |
| Consulting Fee | $2,275.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $10,335.32 | 2019-2025 | Mavyret, Skyrizi, Rinvoq |
| Janssen Pharmaceuticals, INC | $2,662.63 | 2019-2025 | Tremfya |
| E.R. Squibb & Sons, L.L.C. | $525.70 | 2021-2024 | Zeposia |
| Janssen Biotech, INC. | $369.28 | 2020-2025 | Tremfya |
| Organon LLC | $257.14 | 2022-2025 | Renflexis, Hadlima |
| Boston Scientific Corporation | $203.93 | 2019-2023 | Spyglass Discover |
| Pfizer Pharmaceuticals LLC | $158.03 | 2019 | |
| Olympus Latin America, INC. | $146.86 | 2025 | Evis Exera II Ultrasound Gastrovideoscope |
| Gilead Sciences, INC. | $112.27 | 2024 | Epclusa |
| Janssen Scientific Affairs, LLC | $100.00 | 2019 | |
| Pbg Puerto Rico LLC | $74.26 | 2019-2020 | |
| Wyeth Puerto Rico INC | $45.79 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.85 | 2020 | |
| Exact Sciences Corporation | $25.00 | 2025 | Cologuard Collection Kit |
| Amgen INC. | $20.00 | 2023 | Amjevita |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.74 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Vendrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.